Finch Trades

As of market close
October 16, 2026
Update frequency: every Saturday morning
Transaction
Position
Overall
Group
Year
Company
An icon graphic of an arrow.
Ticker
An icon graphic of an arrow.
Entry Date
An icon graphic of an arrow.
Group
An icon graphic of an arrow.
Status
An icon graphic of an arrow.
Cost Basis
An icon graphic of an arrow.
Last Price
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
Click individual row to view transaction details
Adicet Bio
$ACET
10/2/26
Opportunistic
Active
Exited
9985
$6.56
$5.61
$1,000
$855
-14.5%
-15.4%
BridgeBio Oncology Therapeutics
$BBOT
7/8/26
Future Compounder
Active
Exited
9986
$8.74
$2.82
$500
$161
-67.7%
-69.7%
Relay Therapeutics
$RLAY
5/19/26
Future Compounder
Active
Exited
9987
$12.31
$16.28
$950
$1,257
32.3%
28.7%
Relay Therapeutics
$RLAY
5/18/26
Future Compounder
Active
Exited
9988
$12.32
$16.28
$2,500
$3,304
32.1%
29.0%
Relay Therapeutics
$RLAY
5/5/26
Future Compounder
Active
Exited
9989
$12.95
$16.28
$2,500
$3,143
25.7%
20.5%
Relay Therapeutics
$RLAY
3/13/26
Future Compounder
Active
Exited
9990
$10.40
$16.28
$1,250
$1,957
56.5%
41.5%
Relay Therapeutics
$RLAY
3/12/26
Future Compounder
Active
Exited
9991
$10.40
$16.28
$1,250
$1,957
56.5%
42.4%
Coherus Oncology
$CHRS
3/6/26
Future Compounder
Active
Exited
9992
$1.75
$1.2160
$2,500
$1,737
-30.5%
-45.1%
Codexis
$CDXS
3/2/26
Future Compounder
Active
Exited
9993
$1.00
$1.24
$1,000
$1,240
24.0%
12.8%
Harmony Biosciences
$HRMY
2/20/26
Opportunistic
Active
Exited
9994
$30.75
$28.50
$1,750
$1,622
-7.3%
-7.4%
Harmony Biosciences
$HRMY
5/2/25
Current Compounder
Active
Exited
9995
$30.00
$28.50
$23,245
$22,083
-5.0%
-25.7%
Exact Sciences
$EXAS
4/30/25
Opportunistic
Active
Exited
9999
$44.69
$53.05
$10,000
$11,871
18.7%
14.9%
Blueprint Medicines
$BPMC
4/30/25
Opportunistic
Active
Exited
10000
$88.21
$98.73
$10,000
$11,193
11.9%
8.9%
Coherus Oncology
$CHRS
3/27/25
Future Compounder
Active
Exited
$0.86
$1.2200
$250
$355
42.0%
5.8%
Coherus Oncology
$CHRS
1/21/25
Future Compounder
Active
Exited
$1.37
$1.2200
$1,000
$891
-10.9%
-39.1%
Relay Therapeutics
$RLAY
1/10/25
Future Compounder
Active
Exited
$4.32
$16.28
$7,000
$26,392
277.0%
245.5%
AVITA Medical
$RCEL
1/8/25
Future Compounder
Active
Exited
9998
$9.53
$7.45
$1,000
$782
-21.8%
-18.5%
Relay Therapeutics
$RLAY
12/10/24
Future Compounder
Active
Exited
$4.44
$16.28
$2,500
$9,157
266.3%
239.7%
Relay Therapeutics
$RLAY
12/3/24
Future Compounder
Active
Exited
$4.45
$16.28
$2,500
$9,156
266.3%
239.9%
Relay Therapeutics
$RLAY
11/20/24
Future Compounder
Active
Exited
$4.55
$16.28
$2,000
$7,157
257.9%
228.6%
Relay Therapeutics
$RLAY
10/29/24
Future Compounder
Active
Exited
$5.80
$16.28
$1,000
$2,809
180.9%
149.7%
Arrowhead Pharma
$ARWR
10/1/24
Future Compounder
Active
Exited
9996
$18.48
$63.64
$1,000
$3,444
244.4%
224.2%
Relay Therapeutics
$RLAY
9/25/24
Future Compounder
Active
Exited
$7.00
$16.28
$725
$1,686
132.6%
98.7%
Arrowhead Pharma
$ARWR
9/25/24
Future Compounder
Active
Exited
9997
$19.48
$63.64
$1,000
$3,268
226.8%
206.9%
Relay Therapeutics
$RLAY
9/13/24
Future Compounder
Active
Exited
$7.55
$16.28
$1,000
$2,156
115.6%
79.8%
Relay Therapeutics
$RLAY
9/5/24
Future Compounder
Active
Exited
$6.18
$16.28
$2,000
$5,269
163.4%
124.6%
Coherus Oncology
$CHRS
7/2/24
Future Compounder
Active
Exited
$1.40
$1.2200
$1,000
$875
-12.5%
-53.3%
Exact Sciences
$EXAS
5/29/24
Current Compounder
Active
Exited
$44.98
$105.00
$1,000
$2,334
133.4%
108.8%
Relay Therapeutics
$RLAY
5/29/24
Future Compounder
Active
Exited
$6.28
$16.28
$1,000
$2,594
159.4%
114.4%
Coherus Oncology
$CHRS
4/25/24
Future Compounder
Active
Exited
$1.93
$1.2109
$6,996
$4,390
-37.3%
-90.7%
Position
An icon graphic of an arrow.
Ticker
An icon graphic of an arrow.
Group
An icon graphic of an arrow.
Status
An icon graphic of an arrow.
Shares
An icon graphic of an arrow.
Cost Basis
An icon graphic of an arrow.
Last Price
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
Click individual row to view position details
Cash
Cash
$26,372
Relay Therapeutics
$RLAY
Future Compounder
Building
Building
Building
1
4,790.8
$5.88
$16.28
$28,175
$77,994
176.8%
152.5%
Codexis
$CDXS
Future Compounder
Building
Building
Building
2
1,000.0
$1.00
$1.24
$1,000
$1,240
24.0%
12.8%
BridgeBio Oncology Therapeutics
$BBOT
Future Compounder
Full
Full
Full
4
57.2
$8.74
$2.82
$500
$161
-67.7%
-69.7%
Adicet Bio
$ACET
Opportunistic
Exited
Exited
Exited
5
152.4
$6.56
$5.61
$1,000
$855
-14.5%
-15.4%
Coherus Oncology
$CHRS
Future Compounder
Exited
Exited
Exited
993
6,791.3
$1.73
$1.21
$11,746
$8,247
-29.8%
-71.4%
Harmony Biosciences
$HRMY
Opportunistic
Exited
Exited
Exited
994
56.9
$30.75
$28.50
$1,750
$1,622
-7.3%
-7.4%
Harmony Biosciences
$HRMY
Current Compounder
Exited
Exited
Exited
995
774.8
$30.00
$28.50
$23,245
$22,083
-5.0%
-25.7%
Exact Sciences
$EXAS
Current Compounder
Exited
Exited
Exited
996
22.2
$44.98
$105.00
$1,000
$2,334
133.4%
108.8%
Arrowhead Pharma
$ARWR
Future Compounder
Exited
Exited
Exited
997
105.5
$18.96
$63.64
$2,000
$6,712
235.6%
206.9%
AVITA Medical
$RCEL
Future Compounder
Exited
Exited
Exited
998
104.9
$9.53
$7.45
$1,000
$782
-21.8%
-18.3%
Exact Sciences
$EXAS
Opportunistic
Exited
Exited
Exited
999
223.8
$44.69
$53.05
$10,000
$11,871
18.7%
14.9%
Blueprint Medicines
$BPMC
Opportunistic
Exited
Exited
Exited
1000
113.4
$88.21
$98.73
$10,000
$11,193
11.9%
8.9%
For transparency, I also own equity in the following private companies: Genetic Assemblies (autonomous oligo manufacturing), Skyhawk Therapeutics (neuro drug developer)

$53,153

Principal

$106,767

Current Value

100.9%

Total Return
(from April 2024)

32.6%

CAGR
(from April 2024)
Benchmark
An icon graphic of an arrow.
Ticker
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Current Value
An icon graphic of an arrow.
$ Change
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
Finch Trades vs.
An icon graphic of an arrow.
Finch Trades
$FINCH
$53,153
$106,767
$53,615
100.9%
0.0%
If S&P 500
$SPY
$53,153
$69,799
$16,646
31.3%
69.6%
If XBI
$XBI
$53,153
$84,833
$31,680
59.6%
41.3%
If Nasdaq 100
$QQQ
$53,153
$75,181
$22,028
41.4%
59.4%
If ARKG
$ARKG
$53,153
$95,527
$42,374
79.7%
21.1%
Group
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
vs. QQQ
An icon graphic of an arrow.
vs. XBI
An icon graphic of an arrow.
vs. ARKG
An icon graphic of an arrow.
Opportunistic
$22,750
$25,382
11.6%
12.9%
14.1%
15.8%
15.5%
Future Compounder
$44,421
$95,136
114.2%
86.6%
77.8%
66.4%
38.1%
Current Compounder
$24,245
$24,417
0.7%
-20.2%
-23.6%
-50.8%
-30.6%
* This view tracks performance by the portfolio allocation group without accounting for reinvested proceeds.
Year
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
vs. QQQ
An icon graphic of an arrow.
vs. XBI
An icon graphic of an arrow.
vs. ARKG
An icon graphic of an arrow.
2024
$23,721
$54,295
128.9%
91.6%
78.5%
67.4%
48.4%
2025
$52,495
$73,565
40.1%
24.8%
22.5%
7.3%
12.3%
2026
$15,200
$17,170
13.0%
5.7%
4.7%
0.6%
-37.5%
* This view tracks performance by the year principal was invested without accounting for reinvested proceeds.
Research Notes
MOS Dashboard
ABOUT
What Is Solt DB?
Public Benefit
Our Lonely Team
PUBLIC CONTENT
Articles
Data Visualizations
Newsletter
INVESTING
Pricing
Member Benefits
CONTACT
Questions?
Critiques?
Love letters?

Reach out here.
About Solt DB

Solt DB is an equities research firm and public benefit company exploring the business of biotech. For scientists, investors, and nerds of all stripes – or feathers.

Yinz respect the finch n@. 2026 Solt DB.
A white logo of LinkedIn.